Showing results (271-280 of 439) with videos related to

Sort By:
Pageof 44
Cancer Research|February 1, 1994
Two molecular pathways to transitional cell carcinoma of the bladderC H Spruck, P F Ohneseit, M Gonzalez-Zulueta, et al.
Cancer Research|September 1, 1993
Role of chromosome 9 in human bladder cancerN Miyao, Y C Tsai, S P Lerner, et al.
Cancer|May 16, 2006
Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissueSteven S Shen, Carolyn L Smith, Jer-Tsong Hsieh, et al.
European Urology|February 25, 2015
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the LiteratureLuis A Kluth, Peter C Black, Bernard H Bochner, et al.
The Journal of Nutrition|December 1, 2004
Dietary carotenoids and genetic instability modify bladder cancer riskMatthew B Schabath, H Barton Grossman, George L Delclos, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 4, 2024
Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder CancerParminder Singh, Leslie Ballas, Guru P Sonpavde, et al.
European Urology Focus|December 7, 2025
Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 MutationsHeather H Cheng, Sam Callis, Evan Y Yu, et al.
International Journal of Cancer|July 17, 2003
Centrosomal abnormality is common in and a potential biomarker for bladder cancerFeng Jiang, Nancy P Caraway, Anita L Sabichi, et al.
Human Mutation|November 4, 2004
Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolismJordan P Lerner-Ellis, C Melissa Dobson, Timothy Wai, et al.
BJU International|September 6, 2007
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcomeMatthew E Nielsen, Ganesh S Palapattu, Pierre I Karakiewicz, et al.
Pageof 44